← Back to catalogue
ENQUIRE ABOUT THIS RESEARCH COMPOUND →
Performance & Recovery
LL-37
5mg
LL-37 is the active human cathelicidin peptide studied in innate-immunity, antimicrobial, inflammatory-signalling and tissue-response models.
Research focusCathelicidin and innate-immunity research
PresentationLyophilised peptide · 5mg · vial
Research overview
LL-37 is a naturally occurring human host-defence peptide derived from the cathelicidin precursor hCAP18. Research spans antimicrobial activity, immune signalling, inflammation, epithelial biology and tissue-response models.
Evidence status
Experimental / translational research
LL-37 has a substantial preclinical literature, but translating those findings into established human applications remains limited and context dependent.
Research use only. Not for human consumption. This page is educational and does not provide medical advice or dosing guidance.
Areas under investigation
- Host-defence and antimicrobial peptide biology
- Innate-immune and inflammatory signalling
- Epithelial and tissue-response research
Explore the scientific literature
For primary-source reading, use indexed biomedical literature. This research gateway is provided for education rather than endorsement of any particular finding.